GHRS Reports Phase 2b Trial Results: GH001 Shows -2.00 Cohen's d Reduction in MADRS Anhedonia Factor Scores vs Placebo at Day 8
GH Research PLC Ordinary Shares · Now $23.99
+2.7% in 3d after detection
Post-detection moves
1h
—
1d
+1.6%
3d
+2.7%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS